ArticlePloS one2025
Lived experiences and coping strategies of people living with Glaucoma in Nigeria: A qualitative study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Psychological distress and psychosocial care in adults with glaucoma in Africa: A systematic review protocol.PloS one · 2026Article
- Quality of life and its determinants among glaucoma patients attending Berhan Aini Ophthalmic National Referral Hospital: A cross-sectional study.Therapeutic advances in ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe diagnosis of visual impairments and other chronic diseases is associated with frustration, anxiety and depression emanating from potential functional limitations, social restrictions, economic burden and future uncertainties. The impact of glaucoma extends across multiple domains of life. This study explores the lived experiences of people with glaucoma to understand the factors that influence their interactions within the community and how they cope with accompanying challenges.
methodThis study utilised a qualitative research methodology. Data was collected using audio-recorded in-depth semi-structured interviews. Thematic analysis was used to analyse data collected through in-depth interviews.
resultTwelve participants aged 22-65 years old, mostly females (58.3%) participated in the study until saturation. Three major themes emerged from the data. The study identified psychosocial reactions to glaucoma diagnosis expressed with unpleasant emotions, fears and concerns about the future by persons living with glaucoma. Glaucoma impacted daily activities, routines and social life resulting in either reduced social activities or they completely stopped socialising. However, engaging in self-motivation and religious activities were useful strategies to cope with these challenges. Other adaptive and coping strategies included following eye care providers' instructions, attending clinic appointments, making reasonable adjustments at the home and work settings, transferring into accommodation that provides support needs as well as organizing itineraries and activities prior to leaving the house.
conclusionThis study provides evidence of the intricate psychosocial impacts of glaucoma, unravelling a spectrum of emotional reactions and lifestyle adaptations. The emotional stress, fears, and disruptions in daily life underscore the profound challenges posed by this chronic eye condition. Self-motivation and religious engagement emerged as potent coping mechanisms, highlighting the importance of psychological and spiritual support. Additionally, the study identifies practical strategies, from adhering to medical instructions to making environmental adjustments, offering valuable insights for healthcare and support networks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.